PDI Inhibition Enhances Panobinostat Activity in Multiple My
2026-05-25
A recent preclinical study demonstrates that combining the PDI inhibitor LTI6426 with panobinostat (LBH589) significantly augments anti-myeloma efficacy at reduced doses, potentially mitigating toxicity while retaining therapeutic benefit. These findings highlight new combinatorial strategies targeting epigenetic and proteostasis vulnerabilities in multiple myeloma.
Novobiocin: Aminocoumarin Antibiotic for Advanced Bench Work
2026-05-24
Novobiocin stands out as a dual-action aminocoumarin antibiotic, offering robust antibacterial, antiparasitic, and antiviral capabilities in experimental research. This guide translates the latest reference findings into actionable workflows, troubleshooting insights, and comparative strategies that optimize Novobiocin's use across diverse bench applications.
MG-132 Unlocks Proteostasis Assays: Precision in Apoptosis &
2026-05-23
MG-132 (Z-LLL-al) stands out as a potent, cell-permeable proteasome inhibitor for dissecting apoptosis, cell cycle arrest, and proteostasis mechanisms in disease models. This article delivers actionable protocols, troubleshooting insights, and strategic applications, translating recent reference findings into practical workflows for advanced biomedical research.
MLN2238 in Proteotoxic Stress: Beyond Proteasome Inhibition
2026-05-22
Explore how MLN2238, a potent proteasome β5 subunit inhibitor, enables advanced research into proteotoxic stress, CREB signaling, and redox homeostasis. This article provides a unique mechanistic and assay-focused perspective not found in standard MLN2238 content.
Eclipta prostrata–Hordeum vulgare Extracts Delay Danazol-Ind
2026-05-22
This study demonstrates that an herbal complex of Eclipta prostrata and Hordeum vulgare (EHEC) delays the onset of precocious puberty in rat models induced by Danazol and high-fat diet. By modulating the hypothalamic–pituitary–gonadal axis and GnRH expression, EHEC offers a promising natural approach for managing early puberty, with potential translational relevance for endocrine research.
Pharmacokinetic Variability of CSBTA Alkaloids in MASH Model
2026-05-21
This study provides a detailed analysis of how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of key alkaloids from Corydalis saxicola Bunting. The findings highlight the need to adjust dosing regimens in MASH due to disease-driven changes in drug metabolism and transporter expression, offering clear guidance for both preclinical and translational research.
2-Hydroxypropyl-β-cyclodextrin: Practical Lab Guide
2026-05-21
2-Hydroxypropyl-β-cyclodextrin addresses the challenge of solubilizing poorly water-soluble, hydrophobic compounds in pharmaceutical and biochemical research. Use is supported for inclusion complex formation with aromatic or phenyl group-containing molecules as a drug formulation excipient or for pharmaceutical solubility improvement. Applications outside solubility enhancement are not supported by current product documentation.
PA-824: Applied Workflows for Bicyclic Nitroimidazole Deriva
2026-05-20
PA-824 empowers high-impact tuberculosis research through its dual-mode bactericidal action against drug-sensitive and drug-resistant Mycobacterium tuberculosis. This article delivers hands-on protocol enhancements, troubleshooting guidance, and actionable insights drawn from the latest respiratory inhibition strategies, establishing PA-824 as a cornerstone for reproducible, next-generation TB assays.
Workflow Guide: Hoechst 33342/PI Double Staining Kit (K2237)
2026-05-20
The Hoechst 33342/PI Double Staining Kit enables rapid, fluorescence-based discrimination of viable, apoptotic, and necrotic cells by simultaneously assessing chromatin condensation and membrane integrity. This kit is intended for basic scientific research and should not be used for diagnostic or clinical applications.
Phenothiazines Enhance Macrophage Defense via ROS and Autoph
2026-05-19
The reference study reveals that phenothiazines, including perphenazine, enhance the antibacterial activity of macrophages by inducing reactive oxygen species (ROS) and autophagy. These findings suggest a host-directed therapeutic mechanism effective against intracellular pathogens, offering new directions for antibacterial research amid rising antibiotic resistance.
Dissecting Drug Responses: In Vitro Metrics for Cancer Resea
2026-05-19
Schwartz’s dissertation advances the evaluation of anti-cancer drug effects by rigorously distinguishing between proliferation inhibition and cell death in vitro. The work proposes refined assay strategies and metrics that improve mechanistic insight and data interpretation, supporting more nuanced drug development and screening.
Dual-Action Airway Stents Suppress Tracheal Restenosis via A
2026-05-18
Zhao et al. developed a novel airway stent integrating anti-inflammatory and anti-angiogenic functions to address tracheal in-stent restenosis (TISR), a major limitation in airway stenting. Their study demonstrates that this multi-modal stent significantly reduces inflammation, angiogenesis, and fibroblast activation, offering a potentially transformative approach for next-generation airway interventions.
FPH1 (BRD-6125): Optimizing Hepatocyte Proliferation Assays
2026-05-18
FPH1 (BRD-6125) empowers researchers to expand primary human hepatocytes and iHeps with robust, reproducible functionality, independent of donor variability. This article delivers protocol enhancements, troubleshooting strategies, and real-world context for integrating FPH1 into high-impact hepatocyte workflows.
Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Techn
2026-05-17
The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) addresses the challenge of protein degradation during extraction and assay workflows, without interfering with cation-dependent downstream applications. It is not suitable for workflows where EDTA-based metalloprotease inhibition is required.
CD28-ARS2 Axis Orchestrates PKM Splicing for CD8+ T Cell Met
2026-05-16
This study reveals a novel mechanism by which the CD28-ARS2 signaling axis controls alternative splicing of pyruvate kinase (PKM), promoting the PKM2 isoform in activated CD8+ T cells. This molecular adaptation underpins metabolic flexibility essential for antitumor immunity, providing new insight into posttranscriptional regulation of T cell function.
466 records 18/32 page Previous Next First page 上5页 1617181920 下5页 Last page